Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Percy

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
Arthritis and Rheumatism|July 1, 1980
A controlled study of plasma exchange in the treatment of severe rheumatoid arthritisR S Rothwell, P Davis, P A Gordon, et al.
Journal of the National Cancer Institute|September 1, 2022
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical TrialsAndrea M Denicoff, S Percy Ivy, Tami T Tamashiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I StudiesJan H Beumer, Fei Ding, Hussein Tawbi, et al.
The Oncologist|August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer InstituteArjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Thrombosis and Haemostasis|October 18, 1993
Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificityM W Stewart, W S Etches, A S Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trialsPhilip A Philip, Kari Chansky, Michael LeBlanc, et al.
Journal of the National Cancer Institute|November 11, 2015
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer InstituteJoshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 14, 2020
Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MSJulianne L Holleran, Robert A Parise, Jianxia Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering CommitteeLesley Seymour, Susan Groshen, Gary L Rosner, et al.
Investigational New Drugs|January 19, 2010
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumorsJoleen Hubbard, Charles Erlichman, David O Toft, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
Arthritis and Rheumatism|July 1, 1980
A controlled study of plasma exchange in the treatment of severe rheumatoid arthritisR S Rothwell, P Davis, P A Gordon, et al.
Journal of the National Cancer Institute|September 1, 2022
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical TrialsAndrea M Denicoff, S Percy Ivy, Tami T Tamashiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I StudiesJan H Beumer, Fei Ding, Hussein Tawbi, et al.
The Oncologist|August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer InstituteArjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Thrombosis and Haemostasis|October 18, 1993
Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificityM W Stewart, W S Etches, A S Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trialsPhilip A Philip, Kari Chansky, Michael LeBlanc, et al.
Journal of the National Cancer Institute|November 11, 2015
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer InstituteJoshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 14, 2020
Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MSJulianne L Holleran, Robert A Parise, Jianxia Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering CommitteeLesley Seymour, Susan Groshen, Gary L Rosner, et al.
Investigational New Drugs|January 19, 2010
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumorsJoleen Hubbard, Charles Erlichman, David O Toft, et al.
Pageof 23